About Oui Therapeutics
Oui Therapeutics is a company based in New Haven (United States) founded in 2018 by Brian Keenaghan, Leng Lee, and Seth Feuerstein.. Oui Therapeutics has raised $26 million across 6 funding rounds from investors including HHS, First Round Capital and CVS Health Ventures. The company has 9 employees as of December 31, 2024. Oui Therapeutics offers products and services including Digital Therapeutic for Suicide. Oui Therapeutics operates in a competitive market with competitors including Better Therapeutics, SilverCloud, Sincrolab, ieso and Waypoint Health, among others.
- Headquarter New Haven, United States
- Employees 9 as on 31 Dec, 2024
- Founders Brian Keenaghan, Leng Lee, Seth Feuerstein
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Oui Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$26 M (USD)
in 6 rounds
-
Latest Funding Round
$440.09 K (USD), Grant
Jun 05, 2024
-
Investors
HHS
& 2 more
-
Employee Count
9
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Oui Therapeutics
Oui Therapeutics offers a comprehensive portfolio of products and services, including Digital Therapeutic for Suicide. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Prescription-based digital tool to prevent suicide through expert-guided interventions.
Unlock access to complete
Funding Insights of Oui Therapeutics
Oui Therapeutics has successfully raised a total of $26M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $440.09 thousand completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $440,092
-
First Round
First Round
(23 Jul 2020)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2024 | Amount | Grant - Oui Therapeutics | Valuation |
investors |
|
| Sep, 2023 | Amount | Grant - Oui Therapeutics | Valuation |
investors |
|
| Sep, 2022 | Amount | Grant - Oui Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Oui Therapeutics
Oui Therapeutics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, First Round Capital and CVS Health Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused seed and early-stage VC firm
|
Founded Year | Domain | Location | |
|
Venture capital investment for the healthcare industry
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Oui Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Oui Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oui Therapeutics Comparisons
Competitors of Oui Therapeutics
Oui Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Better Therapeutics, SilverCloud, Sincrolab, ieso and Waypoint Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based cardiac therapy planning software is developed for professionals.
|
|
| domain | founded_year | HQ Location |
Mental health programs are delivered through a cloud-based platform.
|
|
| domain | founded_year | HQ Location |
Gamified software for neuropsychological rehabilitation is offered to physicians.
|
|
| domain | founded_year | HQ Location |
Mental health conditions are addressed through AI-powered digital CBT platform.
|
|
| domain | founded_year | HQ Location |
Web-based self-help programs that teach cognitive behavior therapy (CBT) skills
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Oui Therapeutics
When was Oui Therapeutics founded?
Oui Therapeutics was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is Oui Therapeutics located?
Oui Therapeutics is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.
Who is the current CEO of Oui Therapeutics?
Seth Feuerstein is the current CEO of Oui Therapeutics. They have also founded this company.
Is Oui Therapeutics a funded company?
Oui Therapeutics is a funded company, having raised a total of $26M across 6 funding rounds to date. The company's 1st funding round was a Grant of $659.52K, raised on Jul 23, 2020.
How many employees does Oui Therapeutics have?
As of Dec 31, 2024, the latest employee count at Oui Therapeutics is 9.
What does Oui Therapeutics do?
Founded in 2018 and based in New Haven, United States, the company operates in the digital therapeutics sector focused on mental health. Prescription-based digital tools are developed to support suicide prevention efforts. Clinical trials are conducted to assess treatment efficacy, with collaboration involving experts in digital therapy and suicide prevention. Solutions are designed for individuals at risk, emphasizing evidence-based digital interventions.
Who are the top competitors of Oui Therapeutics?
Oui Therapeutics's top competitors include SilverCloud, ieso and Better Therapeutics.
What products or services does Oui Therapeutics offer?
Oui Therapeutics offers Digital Therapeutic for Suicide.
Who are Oui Therapeutics's investors?
Oui Therapeutics has 3 investors. Key investors include HHS, First Round Capital, and CVS Health Ventures.